Latest Statin Stories
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal proceeding established in District of South Carolina for product liability claims alleging the statin medication
Bernstein Liebhard LLP is representing Lipitor Lawsuit plaintiffs in the federal proceeding, which involves allegations that the statin medication caused patients to develop new-onset Type 2 diabetes.
Bernstein Liebhard LLP is representing clients who have filed Lipitor lawsuits in the federal multidistrict litigation. New York, New York (PRWEB) March 31,
Bernstein Liebhard LLP, which is currently representing clients in the federal Lipitor proceeding, reports that the Court has granted Pfizer’s Motion, and has dismissed four individual Lipitor
Court records updated on March 16, 2015 reflect the filing of nearly 2,100 Lipitor lawsuits in the U.S.
Submission of Application in Japan Marks an Important Milestone in Strategic Partnership With Amgen Astellas BioPharma THOUSAND OAKS, Calif., March 20, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN)
Study from NYU Langone Medical Center Shows that Nutrition is Rated as Important as Statins for Preventing Heart Disease NEW YORK, March 16, 2015 /PRNewswire-USNewswire/ -- Most physicians
- Robust and consistent LDL-C lowering demonstrated with Praluent(TM) in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date - PARIS and TARRYTOWN, N.Y., March 15,
Analysis From Prespecified Exploratory Endpoints Presented in Late-Breaking Session at ACC.15 Showed Repatha Plus Standard of Care Lowered Cardiovascular Events THOUSAND OAKS, Calif., March
Robust and consistent LDL-C lowering demonstrated with Praluent(TM) in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date TARRYTOWN, N.Y.
- Growing in low tufty patches.